Covered recipient · General Payments record
SHERI DENHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,371.70
- Reported across 175 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $689.34 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Indivior Inc. | $105.24 | 4 |
| REVANCE THERAPEUTICS, INC. | $105.21 | 4 |
| Braeburn Inc. | $102.04 | 5 |
| Lilly USA, LLC | $99.73 | 5 |
| ABBVIE INC. | $97.64 | 5 |
| Alkermes, Inc. | $50.32 | 2 |
| Lundbeck LLC | $39.00 | 2 |
| Vanda Pharmaceuticals Inc. | $37.54 | 2 |
| Novo Nordisk AS | $31.23 | 2 |
| ITI, Inc. | $21.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012019 | CMS |
| ABBVIE INC. | $19.41 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012021 | CMS |
| ABBVIE INC. | $17.55 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012023 | CMS |
| ABBVIE INC. | $21.98 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012025 | CMS |
| ABBVIE INC. | $13.70 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107012027 | CMS |
| Alkermes, Inc. | $22.07 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120489602 | CMS |
| Alkermes, Inc. | $28.25 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120489604 | CMS |
| Braeburn Inc. | $21.04 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125623085 | CMS |
| Braeburn Inc. | $21.03 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125623088 | CMS |
| Braeburn Inc. | $14.91 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125623096 | CMS |
| Braeburn Inc. | $19.56 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125623092 | CMS |
| Braeburn Inc. | $25.50 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125623100 | CMS |
| Indivior Inc. | $21.08 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144549795 | CMS |
| Indivior Inc. | $21.07 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144549797 | CMS |
| Indivior Inc. | $33.20 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144549799 | CMS |
| Indivior Inc. | $29.89 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144549801 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $21.39 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143426920 | CMS |
| Lilly USA, LLC | $22.69 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949090 | CMS |
| Lilly USA, LLC | $21.99 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949476 | CMS |
| Lilly USA, LLC | $17.08 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135949478 | CMS |
| Lilly USA, LLC | $18.54 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135865584 | CMS |
| Lilly USA, LLC | $19.43 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135865588 | CMS |
| Lundbeck LLC | $21.05 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146013227 | CMS |
| Lundbeck LLC | $17.95 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146013229 | CMS |
| Novo Nordisk Inc | $14.57 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100536875 | CMS |
| Novo Nordisk Inc | $16.66 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100396536 | CMS |
| REVANCE THERAPEUTICS, INC. | $31.14 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938081 | CMS |
| REVANCE THERAPEUTICS, INC. | $32.68 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938083 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.11 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938085 | CMS |
| REVANCE THERAPEUTICS, INC. | $24.28 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147938087 | CMS |
| Vanda Pharmaceuticals Inc. | $17.94 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133939338 | CMS |
| Vanda Pharmaceuticals Inc. | $19.60 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133939340 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.